How not to neglect the care of elderly breast cancer patients?

Breast

Volumn 20, Issue 4, 2011, Pages 293-296

  Tahir, M ^a   Robinson, T ^a   Stotter, A ^a  

^a UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

Author keywords

Breast cancer; Comprehensive geriatric assessment; Elderly

Indexed keywords

AROMATASE INHIBITOR; TAMOXIFEN; TRASTUZUMAB;

ADJUVANT THERAPY; AGE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMORBIDITY; DRUG EFFICACY; DRUG SAFETY; ELDERLY CARE; HUMAN; INTERMETHOD COMPARISON; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; TREATMENT INDICATION;

EID: 79960602438     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2011.03.003     Document Type: Review

References (43)

1. Garcia M., Jemal A., Ward E.M., Center M.M., Hao Y., Siegel R.L., et al. Global cancer facts & figures 2007 2007, American Cancer Society, Atlanta, GA.
2. August D.A., Rea T., Sondak V.K. Age-related differences in breast cancer treatment. Ann Surg Oncol 1994 Jan, 1(1):45-52. PMID: 7834427].
3. Quinn M., Babb P., Brock A., Kirby L., Jones J. Cancer trends in England and Wales, 1950-1999. Studies on medical and population subjects, No. 66 National Statistics, UK 2001, The Stationary Office, London, (pp.) 42-43.
4. Tabar L., Yen M.-F., Vitak B., Chen H.-H.T., Smith R.A., Duffy S.W. Mammography service screening and mortality in breast cancer patients: 20 year follow-up before and after introduction of screening. Lancet 2003, 361:1405-1410.
5. Golledge J., Wiggins J.E., Callam M.J. Age-related variation in the treatment and outcomes of patients with breast carcinoma. Cancer 2000, 88:369-374.
6. Yancik R., Wesley M.N., Ries L.A.G., Havlik R.J., Edwards B.K., Yates J.W. Effect of age and comorbidity in post-menopausal breast cancer patients aged 55 years and older. J Am Med Assoc 2001, 285:885-892.
7. Wyld L., Garg D.K., Kumar I.D., Brown H., Reed M.W.R. Stage and treatment variation with age in postmenopausal women with breast cancer: compliance with guidelines. Br J Cancer 2004, 90:1486-1491.
8. Wanebo H.J., Cole B., Chung M., Vezeridis M., Schepps B., Fulton J., et al. Is surgical management compromised in elderly patients with breast cancer?. Ann Surg 1997, 225:579-586. [PMC free article]. 10.1097/00000658-199705000-00014.
9. Mandelblatt J.S., Hadley J., Kerner J.F., Schulman K.A., Gold K., Dunmore-Griffith J., et al. Patterns of breast carcinoma treatment in older women: patient preference and clinical and physical influences. Cancer 2000, 89:561-573. 10.1002/1097.
10. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 365:1687-1717. Early Breast Cancer Trialists' Collaborative Group (EBCTCG).
11. Satariano W.A., Ragland D.R. The effect of co-morbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 1994, 120:104-110.
12. Turner N.J., Haward R.A., Mulley G.P., Selby P.J. Cancer in old age - is it inadequately investigated and treated?. BMJ 1999, 319:309-312. [PMC free article].
13. Hurria A., Leung D., Trainor K., Borgen P., Norton L., Hudis C. Factors influencing treatment patterns of breast cancer patients age 75 and older. Crit Rev Oncol Hematol 2003, 46:121-126.
14. Audisio Riccardo A. The surgical risk of elderly patients with cancer. Surg Oncol 2004, 13(4):169.
15. Gennari R., Curigliano G., Rotmensz N., Robertson C., Colleoni M., Zurrida S. Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with younger postmenopausal patients. Cancer 2004, 101:1302-1310.
16. Wildiers H., Kunkler I., Biganzoli L., Fracheboud J., Vlastos G., Bernard-Marty C., et al. Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology. Lancet Oncol 2007, 8:1101-1115. International Society of Geriatric Oncology.
17. Monypenny I. UK symptomatic breast audit 1.4.2001-31.3.2002 2003, British Association of Surgical Oncology.
18. Hind D., Wyld L., Reed M.W. Surgery, with or without tamoxifen, vs tamoxifen alone for older women with operable breast cancer: cochrane review. Br J Cancer 2007 Apr 10, 96(7):1025-1029. Epub 2007 Feb 6.
19. Fennessey M., Bates T., McRae K., Riley D., Houghton J., Baum M. Randomised trial of surgery plus tamoxifen vs tamoxifen-alone in women over age 70 with operable breast cancer. Br J Surg 2004, 91:699-704.
20. Mustacchi G., Ceccherini R., Milani S., Pluchinotta A., De Matteis A., Maiorino L., et al. Tamoxifen alone versus adjuvant tamoxifen for operable breast cancer of the elderly: long-term results of the phase III randomised controlled multicenter GRETA trial. Ann Oncol 2003, 14:414-420.
21. Fentiman I.S., Christiaens M.-R., Paridaens R., Van Geel A., Rutgers E., Berner J., et al. Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomy. Eur J Cancer 2003, 39:309-316.
22. Robertson J.F., Ellis I.O., Elston C.W., Blamey R.W. Mastectomy or tamoxifen as initial therapy for operable breast cancer in elderly patients: 5-year follow up. Eur J Cancer 1992, 28A:908-910.
23. Gazet J.-C., Ford H.T., Coombes R.C., Bland J.M., Sutcliffe R., Quilliam J., et al. Prospective randomised trial of tamoxifen vs surgery in elderly patients with breast cancer. Eur J Surg Oncol 1994, 20:207-214.
24. Guidance on cancer Services: Improving outcomes in breast cancer. Manual Update 2002, National Institute for Clinical Excellence, NICE, London.
25. Howell A., Cuzick J., Baum M., Buzdar A., Dowsett M., Forbes J.F., et al. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet 2005, 365:60-62.
26. Ingle J.N., Suman V.J. Aromatase inhibitors versus tamoxifen for management of postmenopausal breast cancer in the advanced disease and neoadjuvant settings. J Steroid Biochem Mol Biol 2003, 86:313-319.
27. Cummings S.R., Melton L.J. Epidemiology and outcomes of osteoporotic fractures. Lancet 2002, 359:1761-1767.
28. Clarke M., Collins R., Darby S., Davies C., Elphinstone P., Evans E., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials. Lancet 2005, 366:2087-2106. Early Breast Cancer Trialists' Collaborative Group (EBCTCG).
29. Diab S.G., Elledge R.M., Clark G.M. Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 2000, 92:550-556.
30. Wyld L., Reed M.W. The need for targeted research into breast cancer in the elderly. Br J Surg 2003, 90:388-399.
31. Piccart-Gebhart M.J., Procter M., Leyland-Jones B., Goldhirsch A., Untch M., Smith I., et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 2005, 353:1659-1672.
32. Romond E.H., Perez E.A., Bryant J., Suman V.J., Geyer C.E., Davidson N.E., et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 2005, 353:1673-1684. 10.1056/NEJMoa052122.
33. Rubenstein L.Z. An overview of comprehensive geriatric assessment: rationale, history, program models, basic components. Geriatric assessment technology: the state of the art 1995, Springer, New York, NY. L.Z. Rubenstein, D. Wieland, R. Bernabei (Eds.).
34. Handbook of geriatric assessment 2000, Aspen, Gaithersburg, Md. 3rd ed. J.J. Gallo, T. Fulmer, G.J. Paveza (Eds.).
35. Buchner D.M., Wagner E.H. Preventing frail health. Clin Geriatr Med 1992, 8:1-17.
36. Freedman V.A., Martin L.G., Schoeni R.F. Recent trends in disability and functioning among older adults in the United States: a systematic review. JAMA 2002, 288(24):3137-3146.
37. Charlson M.E., Pompei P., Ales K., MacKenzie C.R. A new method of classifying comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
38. McGuire L.C., Ford E.S., Ajani U.A. The impact of cognitive functioning on mortality and the development of functional disability in older adults with diabetes: the second longitudinal study on aging. BMC Geriatr 2006 May 1, 6:8. PMID: 16650284.
39. Stump T.E., Callahan C.M., Hendrie H.C. Cognitive impairment and mortality in older primary care patients. J Am Geriatr Soc 2001 Jul, 49(7):934-940. PMID: 11527485.
40. Carey E.C., Walter L.C., Lindquist K., Covinsky K.E. Development and validation of a functional morbidity index to predict mortality in community-dwelling elders. J Gen Intern Med 2004 Oct, 19(10):1027-1033. PMID: 15482555.
41. Scott W.K., Macera C.A., Cornman C.B., Sharpe P.A. Functional health status as a predictor of mortality in men and women over 65. J Clin Epidemiol 1997, 50:291-296.
42. Wolters U., Wolf T., Stützer H., Schröder T. ASA classification and perioperative variables as predictors of postoperative outcome. Br J Anaesth 1996 Aug, 77(2):217-222. PMID: 8881629.
43. Menke H., Klein A., John K.D., Junginger T. Predictive value of ASA classification for the assessment of the perioperative risk. Int Surg 1993 Jul-Sep, 78(3):266-270. PMID: 8276556.